MIRA Surgical System
World's first Miniaturized Robotic-Assisted Surgery (miniRAS) system
Company profile
Company profile
Virtual Incision is on a mission to miniaturize robotic surgery, making robotic-assisted surgery (RAS) more accessible to patients, surgeons, and healthcare facilities. The company has developed MIRA, the world's first Miniaturized Robotic-Assisted Surgery (miniRAS) system, which represents a significant departure from traditional mainframe robotic surgery systems. MIRA's compact, tray-to-table design aims to accelerate the adoption of RAS by fitting within existing hospital infrastructure, either as a complement to mainframe systems or as a stand-alone solution. The system enables surgery to be performed with precision through small incisions, potentially resulting in low conversions to open surgery, short hospital stays, and reduced complications. Virtual Incision addresses a critical access problem in robotic surgery: the complexity of mainframe RAS systems limits how many surgeries can be performed, leaving millions of patients without access to these benefits. By miniaturizing the technology, Virtual Incision seeks to enable more surgeries per day, allowing more patients to benefit from robotic-assisted procedures. The company has successfully completed procedures including hysterectomies with the MIRA system and has demonstrated remote robotic-assisted surgery capabilities through collaborations with partners including Sovato, City of Hope, and University of Illinois Chicago. Virtual Incision is exploring advanced technologies including NVIDIA Isaac for Healthcare to enhance its surgical robotics capabilities.
Company description Virtual Incision official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
On Premise deployment with recorded integration context.
Company milestones
Jim Alecxih appointed as CEO (June 2025). First hysterectomy completed with MIRA system (July 2024). Remote robotic-assisted surgery demonstration completed (November 2024). Exploring NVIDIA Isaac for Healthcare integration (March 2025).
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
World's first Miniaturized Robotic-Assisted Surgery (miniRAS) system
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Annals of surgery · Aug 19, 2026
Enabling Technologies for Remote Surgery.Military medicine · Sep 1, 2025
End-Effector Contact and Force Detection for Miniature Autonomous Robots Performing Lunar and Expeditionary Surgery.Military medicine · Jan 25, 2021
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Robotic-assisted surgery with MIRA system
Minimally invasive surgery through small incisions
Precision surgery enabled by robotic assistance
U.S.-based remote robotic-assisted surgery demonstration
Successfully completed remote robotic-assisted surgery demonstration
First hysterectomy performed with MIRA Surgical System
Successful completion of first hysterectomy procedure with MIRA
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Virtual Incision's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.